Author | Zahi Mitri, MD, MS | OncLive

Author | Zahi Mitri, MD, MS

Articles

Dr. Mitri on the Treatment Landscape of HER2+ Breast Cancer

June 29, 2018

Video

Zahi Mitri, MD, MS, assistant professor of medicine, Oregon Health and Science University, discusses the treatment landscape of HER2-positive breast cancer.

Dr. Mitri on Neratinib and Pertuzumab in HER2-Amplified Breast Cancer

June 19, 2018

Video

Zahi Mitri, MD, MS, assistant professor of medicine, Oregon Health and Science University, discusses the use of neratinib (Nerlynx) and pertuzumab (Perjeta) in patients with HER2-amplified breast cancer.

x